Intrinsic coating morphology modulates acute drug transfer in drug-coated balloon therapy

Gary H. Chang, D. Azar, Chimera Lyle, Vipul C. Chitalia, Tarek Shazly, Vijaya B. KolachalamaScientific 2019 · DOI

TL;DR

This study investigates how the microscopic structure of drug-coated balloon (DCB) coatings, specifically using urea and shellac excipients, influences drug transfer to arterial walls. By combining mechanical testing, electron microscopy, and biophysical modeling, the researchers found that the distinct spherical (shellac) and conical (urea) microstructures lead to different force distributions and drug transfer efficiencies, highlighting the critical role of excipient morphology in DCB design.

What Problem Does This Paper Address?

Peripheral Arterial Disease (PAD) affects millions worldwide, and drug-coated balloon (DCB) therapy offers a promising stent-free approach to reopen narrowed arteries and deliver drugs locally. However, current DCB designs suffer from poor drug delivery efficiency, with a significant portion of the drug being lost. This inefficiency stems from a limited understanding of how the drug coating interacts with both the balloon and the arterial wall, as well as site-specific variations. The paper aims to bridge this knowledge gap by dissecting the influence of excipient microstructure on the mechanical interactions during balloon deployment and subsequent drug transfer.

Methods

The researchers employed a multi-pronged approach:

  • Scanning Electron Microscopy (SEM): Used to visualize and characterize the distinct microstructural morphologies of shellac (spherical) and urea (conical/needle-like) coatings.
  • Uniaxial Mechanical Testing: Coated balloon materials were compressed against both rigid surfaces and excised porcine arterial vessels. This allowed for the measurement of force-displacement curves to determine the compliance of the balloon coatings and the combined balloon-artery system.
  • Biophysical Modeling (Hertz Theory): Adapted classic Hertz theory to model the elastic contact mechanics between the distinct coating microstructures (spheres and cones) and the arterial wall. This enabled the calculation of mean contact pressure, a key metric for understanding force distribution at the microscopic level.
  • Arterial Drug Transfer Measurement: After mechanical testing, the amount of paclitaxel (PTX) transferred to the arterial vessel was quantified using High-Performance Liquid Chromatography (HPLC).
  • Cell-Based Assays: Human umbilical endothelial cells were exposed to varying concentrations of shellac and urea to assess their cytotoxicity using LIVE/DEAD staining and ATP release assays.

Datasets

Not explicitly discussed as datasets in the traditional machine learning sense. The study utilized:

  • Explanted Porcine Femoral Arteries: Obtained from local abattoirs for mechanical testing and drug transfer measurements.
  • Human Umbilical Endothelial Cells: Used for in vitro cytotoxicity assays.

Key Insights and Ideas

  • Morphology Matters: The intrinsic shape of the coating microstructure (spherical for shellac vs. conical for urea) fundamentally alters how forces are transmitted to the arterial wall, even under the same applied balloon pressure.
  • Hertz Theory Adaptation: The successful application of Hertz theory to model the contact mechanics of these distinct microstructures provides a powerful framework for predicting coating-artery interactions.
  • Contact Pressure as a Predictor: Mean contact pressure, derived from the coating's shape and applied force, emerged as a crucial factor correlating with acute drug transfer, particularly for urea.
  • Differential Cytotoxicity: Shellac, at higher concentrations, demonstrated a dose-dependent decrease in endothelial cell viability compared to urea, suggesting potential implications for tissue healing and response.

Key Results

  • SEM Findings: Shellac coatings exhibited spherical microstructures (mean radius ~0.84 µm), while urea coatings showed needle-like crystalline microstructures (mean length ~21.6 µm).
  • Mechanical Testing: No statistically significant differences were found in the bulk compliance of shellac and urea-coated balloons when compressed on flat surfaces or arterial vessels. This suggests that at a macroscopic level, their mechanical behavior is similar.
  • Contact Pressure: Mean contact pressure was significantly different between shellac and urea coatings, with urea generally exhibiting higher values under equivalent applied forces. The normalized contact radius (a₀/R) also differed significantly.
  • Drug Transfer Correlation: Acute drug transfer showed a stronger correlation with mean contact pressure for urea (R²=0.45) than for shellac (R²=0.05).
  • Cytotoxicity: Low concentrations of both shellac and urea showed minimal impact on endothelial cell viability. However, shellac at higher concentrations (100-500 µM) led to increased cell death and reduced ATP production compared to urea.

Limitations and Future Work

  • Ex Vivo Arterial Models: The study used explanted porcine arteries, which may have altered structural integrity compared to in vivo conditions. Future work could involve in vivo studies.
  • Simplified Mechanical Model: The Hertz theory model assumed linear elastic behavior, which might not fully capture the complex, non-linear mechanics of tissue interaction at larger strains.
  • Cohesive vs. Adhesive Failure: The study did not isolate the roles of cohesive and adhesive bond forces in coating detachment, which are critical for understanding drug retention.
  • Future Directions: The authors suggest that their paradigm can be extended to evaluate a broader range of excipients to design formulations that maximize balloon transfer, arterial uptake, and minimize systemic loss. Further investigation into the long-term effects of these excipients on tissue healing and the interplay of cohesive/adhesive forces is warranted.

Summary updated

Abstract

The hallmark of drug-coated balloon (DCB) therapy for the treatment of peripheral vascular disease is that it allows for reopening of the narrowed lumen and local drug delivery without the need for a permanent indwelling metal implant such as a stent. Current DCB designs rely on transferring drugs such as paclitaxel to the arterial vessel using a variety of biocompatible excipients coated on the balloons. Inherent procedural challenges, along with limited understanding of the interactions between the coating and the artery, interactions between the coating and the balloon as well as site-specific differences, have led to DCB designs with poor drug delivery efficiency. Our study is focused on two clinically significant DCB excipients, urea and shellac, and uses uniaxial mechanical testing, scanning electron microscopy (SEM), and biophysical modeling based on classic Hertz theory to elucidate how coating microstructure governs the transmission of forces at the coating-artery interface. SEM revealed shellac-based coatings to contain spherical-shaped microstructural elements whereas urea-based coatings contained conical-shaped microstructural elements. Our model based on Hertz theory showed that the interactions between these intrinsic coating elements with the arterial wall were fundamentally different, even when the same external force was applied by the balloon on the arterial wall. Using two orthogonal cell-based assays, our study also found differential viability when endothelial cells were exposed to titrated concentrations of urea and shellac, further highlighting the need to maximize coating transfer efficiency in the context of DCB therapies. Our results underscore the significance of the excipient in DCB design and suggest that coating microstructure modulates acute drug transfer during device deployment.
BibTeX
@inproceedings{chang2019intrinsic,
  author = {Gary H. Chang and D. Azar and Chimera Lyle and Vipul C. Chitalia and Tarek Shazly and Vijaya B. Kolachalama},
  title = {{Intrinsic coating morphology modulates acute drug transfer in drug-coated balloon therapy}},
  booktitle = {Scientific},
  year = {2019},
  doi = {10.1038/s41598-019-43095-9},
}
Figure